CORT
CORCEPT THERAPEUTICS INC · Healthcare · Market cap $12.6B
Insiders sold $53.9M net in the last 90 days ·9 sellers, 0 buyers· 20 of 23 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 16, 2026
Insider Buying
$3.3M
reported purchases (SEC code P)
Insider Selling
$101.2M
reported sales (SEC code S)
Unique Insiders
11
in the rolling window
Latest filing
Oct 16, 2026
WILSON JAMES N
CORCEPT THERAPEUTICS INC (CORT) has 85 SEC Form 4 filings (266 transaction rows) in the rolling window, disclosed by 11 distinct insiders. Most recent filing: Oct 16, 2026.
Inside the rolling window, 11 insiders at CORCEPT THERAPEUTICS INC reported 1 open-market purchase totaling $3.3M and 54 open-market sales totaling $101.2M. The most active filer is Chief Development Officer Guyer William with 13 filings. Insiders have net sold $83.3M over the trailing 6 months. The most recent open-market filing is a sale of 10,000 shares by Director WILSON JAMES N, dated Oct 15, 2026, worth $1.1M.
- Industry:Medical - Pharmaceuticals
- CEO:Joseph K. Belanoff
- Employees:730
- HQ:Redwood City, CA, US
- IPO:2004-04-14
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director | Sale | 10,000 | $1.1M | Oct 16 | +5.6% | SEC ↗ | |
| President, Oncology | Sale | 8,333 | $967K | Oct 5 | -4.7% | SEC ↗ | |
| See Remarks | Sale | 810 | $93K | Oct 5 | -4.7% | SEC ↗ | |
| See Remarks | Sale | 9,190 | $1.1M | Oct 5 | -4.7% | SEC ↗ | |
| See Remarks | Sale | 413 | $48K | Oct 5 | -4.7% | SEC ↗ | |
| See Remarks | Sale | 24,587 | $2.9M | Oct 5 | — | SEC ↗ | |
| President, Oncology | Sale | 296 | $30K | Sep 18 | — | SEC ↗ | |
| Director | Sale | 10,000 | $1.1M | Sep 16 | — | SEC ↗ | |
| See Remarks | Sale | 10,000 | $1.1M | Sep 16 | — | SEC ↗ | |
| See Remarks | Sale | 25,000 | $2.9M | Sep 4 | — | SEC ↗ | |
Vieira Roberto WandenkolkFirst filing | President, Oncology | Sale | 58,333 | $6.5M | Sep 4 | — | SEC ↗ |
Park KimberlyFirst filing | Director | Sale | 26,685 | $3.3M | Aug 28 | — | SEC ↗ |
| See Remarks | Sale | 30,955 | $3.9M | Aug 27 | — | SEC ↗ | |
| Director | Sale | 103,606 | $12.3M | Aug 20 | — | SEC ↗ | |
| See Remarks | Sale | 3,664 | $419K | Aug 18 | — | SEC ↗ | |
| Director | Sale | 10,000 | $1.1M | Aug 18 | — | SEC ↗ | |
Robb Gary CharlesFirst filing | Chief Business Officer | Sale | 10,000 | $1.2M | Aug 18 | — | SEC ↗ |
| Chief Development Officer | Sale | 16,300 | $1.8M | Aug 12 | — | SEC ↗ | |
| See Remarks | Sale | 1,031 | $118K | Aug 12 | — | SEC ↗ | |
| Chief Development Officer | Sale | 3,700 | $419K | Aug 6 | — | SEC ↗ | |
| See Remarks | Sale | 20,305 | $2.3M | Aug 5 | — | SEC ↗ | |
| See Remarks | Sale | 1,540 | $176K | Aug 5 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 80,000 | $9.2M | Aug 3 | — | SEC ↗ | |
| Director | Sale | 10,000 | $883K | Jul 17 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 40,000 | $3.5M | Jul 17 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does CORT have?
CORCEPT THERAPEUTICS INC (CORT) has 85 SEC Form 4 filings (266 transaction rows) in the rolling 365-day window, disclosed by 11 distinct insiders. Most recent filing: Oct 16, 2026.
When was the most recent SEC Form 4 filing for CORT?
The most recent Form 4 filing for CORT on Tracefour is dated Oct 16, 2026.
Who is the most active insider at CORT?
The most active SEC Form 4 filer at CORT in the rolling window is Chief Development Officer Guyer William, with 13 filings.
What is the net insider flow at CORT over the last 6 months?
Over the trailing 180 days, insiders at CORT have net sold $83.3M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at CORT in the current window?
Inside the rolling window, insiders at CORT bought $3.3M and sold $101.2M based on SEC Form 4 filings.
Can I get alerts for CORT insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at CORCEPT THERAPEUTICS INC (CORT). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
CORCEPT THERAPEUTICS INC is in the Healthcare sector.